Susan P. Stimson, Chief Strategy Officer at Intersect ENT, Inc. (XENT), sold 10,000 shares at $29.13 ($291K) on 2019-04-10, disclosed to the SEC on 2019-04-12.
Open-market sale of $291k XENT by Chief Strategy Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| XENT | SELL | 2019-05-01 | $388K | — | Filing → |
| XENT | SELL | 2019-04-24 | $80K | — | Filing → |